Lyric Pharmaceuticals Secures $20,400,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f7f12728-2b66-419c-9586-47f932799723 - Date
3/2/2015 - Company Name
Lyric Pharmaceuticals - Mailing Address
601 Gateway Boulevard South San Francisco, CA 94080 USA - Company Description
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting. - Website
http://www.lyricpharma.com - Transaction Type
Venture Equity - Transaction Amount
$20,400,000 - Transaction Round
Series A - Proceeds Purposes
The current financing will enable the company to perform two clinical studies, including a clinical proof of concept study, in addition to other supportive activities. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
